WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Effects of a Calorie Restricted, Very Low Fat Plant-based Diet and Multi-component Exercise Program on Metabolic Health

Not Applicable

Completed

Conditions: Insulin Resistance
Obesity

Interventions: Other: Weight loss with very low fat plant-based diet and regular exercise

First Posted Date: 2016-03-11

Last Posted Date: 2022-12-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 8

Registration Number: NCT02706288

Locations: 🇺🇸
Washington University in St. Louis School of Medicine, Saint Louis, Missouri, United States

Complex Effects of Dietary Manipulation on Metabolic Function, Inflammation and Health

Not Applicable

Recruiting

Conditions: Obesity
Insulin Resistance

Interventions: Other: Metabolically abnormal obese - Mediterranean diet
Other: Metabolically abnormal obese - Low carbohydrate ketogenic diet
Other: Metabolically abnormal obese - Plant-based, very-low-fat diet

First Posted Date: 2016-03-11

Last Posted Date: 2024-05-24

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 180

Registration Number: NCT02706262

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Pilot Trial of External Warming in Septic Patients

Not Applicable

Completed

Conditions: Sepsis

Interventions: Other: External warming

First Posted Date: 2016-03-11

Last Posted Date: 2020-04-28

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 60

Registration Number: NCT02706275

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC)

Phase 2

Withdrawn

Conditions: Carcinoma, Non-Small-Cell Lung
Non-Small Cell Lung Cancer
Nonsmall Cell Lung Cancer

Interventions: Drug: Rociletinib
Procedure: Biopsy
Procedure: Blood draw

First Posted Date: 2016-03-10

Last Posted Date: 2016-05-17

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT02705339

CD36 and Human Fat Taste Perception

Completed

Conditions: Obesity

Interventions: Other: No intervention

First Posted Date: 2016-03-04

Last Posted Date: 2016-03-04

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 97

Registration Number: NCT02699567

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

The Impact Of The Addition Of Budesonide To Low-Pressure, High-Volume Saline Sinus Irrigation For Chronic Rhinosinusitis

Phase 4

Completed

Conditions: Rhinosinusitis
Chronic Eosinophilic Rhinosinusitis
Allergic Rhinosinusitis

Interventions: Drug: Saline alone
Drug: Budesonide

First Posted Date: 2016-03-02

Last Posted Date: 2019-09-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 80

Registration Number: NCT02696850

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors

Phase 2

Withdrawn

Conditions: Glioma
Rhabdomyosarcoma
Osteosarcoma
Medulloblastoma
Neuroectodermal Tumor
Ependymoma
Ewing's Sarcoma
Wilms Tumor

Interventions: Biological: Erlotinib
Drug: Temozolomide

First Posted Date: 2016-02-23

Last Posted Date: 2019-09-09

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT02689336

Understanding Clinical Phenotype and Collecting Biomarker Samples in C9ORF72 ALS

Completed

Conditions: C9ORF72 Amyotrophic Lateral Sclerosis (ALS)

First Posted Date: 2016-02-19

Last Posted Date: 2021-07-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 128

Registration Number: NCT02686268

Locations: 🇺🇸
Johns Hopkins, Baltimore, Maryland, United States
🇳🇱
UMC Utrecht, Utrecht, Netherlands
🇺🇸
University of Massachusetts, Amherst, Massachusetts, United States

and more 5 locations

Pneumonia in the Intensive Care Unit (ICU) Setting

Completed

Conditions: Respiratory Failure
Pneumonia

Interventions: Behavioral: Antibiotic de-escalation by ICU stewardship team with decreased exposure to broad spectrum antibiotics and shorter duration of therapy

First Posted Date: 2016-02-19

Last Posted Date: 2018-05-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 364

Registration Number: NCT02685930

Locations: 🇺🇸
Barnes-Jewish Hospital, Saint Louis, Missouri, United States

DHEA in Synovial Sarcoma Patients

Phase 1

Terminated

Conditions: Synovial Sarcoma
Sarcoma, Synovial

Interventions: Drug: DHEA
Other: FACT-67 validated survey

First Posted Date: 2016-02-17

Last Posted Date: 2019-09-09

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 11

Registration Number: NCT02683148

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy